MOG and myeloid sarcoma: Two patients (1 with a low-positive anti-MOG result, 1 with a clear-positive anti-MOG result) could not be classified as TP or FP with confidence and were also excluded from further analysis; both patients had attacks compatible with demyelination but were pending investigations to help distinguish between MOGAD and MS.